Articles on Virus variants

Displaying all articles

Rapid tests are inexpensive, easy to use and give fast results, usually within 10 to 15 minutes. Violeta Stoimenova/E+ via Getty Images

COVID‑19 rapid tests still work against new variants – researchers keep ‘testing the tests,’ and they pass

Nathaniel Hafer, UMass Chan Medical School; Anuradha Rao, Emory University, and Apurv Soni, UMass Chan Medical School

Research shows that rapid antigen tests are performing as well at detecting the most recent dominant variants as they did with the earliest strains in the COVID-19 pandemic.
The FDA advisory committee discussed vaccine safety, effectiveness of the current shots, potential seasonality of COVID-19 and more. wildpixel/iStock via Getty Images Plus

FDA advisory committee votes unanimously in favor of a one‑shot COVID‑19 vaccine approach – 5 questions answered

Matthew Woodruff, Emory University

Many questions remain about next steps for US vaccine policy. But the FDA advisory panel’s hearty endorsement of a single-composition COVID-19 vaccine represents a pivotal step.
Millions of U.S. children between the ages of 6 months and 4 years will soon be eligible for COVID-19 shots. FatCamera/E+ via Getty Images

At last, COVID‑19 shots for little kids – 5 essential reads

Amanda Mascarelli, The Conversation

The FDA’s authorization of COVID-19 shots for children ages 6 months to 4 years will bring relief for millions of parents. Pending CDC endorsement, shots for this group will be available within days.
Viral surveillance and prediction may be key parts of figuring out what goes into a vaccine. Pexels Cover/500px via Getty Images

Future COVID‑19 booster shots will likely need fresh formulations as new coronavirus variants of concern continue to emerge

David R. Martinez, University of North Carolina at Chapel Hill

A new generation of vaccines and boosters against SARS-CoV-2 may take a page from the anti-influenza playbook, with shots periodically tailored to target the most commonly circulating virus strains.
Millions of U.S. children ages 5-11 have already received at least one dose of the COVID-19 vaccine. Keith Birmingham/MediaNews Group/Pasadena Star-News via Getty Images

COVID‑19 vaccines for the youngest children may be inching closer to authorization – a pediatrician explains how they’re being tested

Debbie-Ann Shirley, University of Virginia

Moderna will ask the FDA to allow emergency use for its vaccine in children as young as 6 months, a step many parents have been anticipating.
The omicron variant possesses numerous mutations in the spike protein, the knob-like protrusions (in red) that allow the virus to invade other cells. Juan Gaertner/Science Photo Library via Getty Images

Will omicron – the new coronavirus variant of concern – be more contagious than delta? A virus evolution expert explains what researchers know and what they don’t

Suresh V. Kuchipudi, Penn State

It’s too early to say whether the newly identified omicron variant is going to overtake delta. But particular mutations in the new strain have researchers deeply concerned.

Related Topics

  1. COVID-19
  2. COVID-19 vaccine boosters
  3. COVID-19 vaccines
  4. COVID-19 vaccines and variants
  5. COVID-19 variants
  6. Food and Drug Administration (FDA)
  7. Influenza
  8. Pandemic
  9. SARS-CoV-2
  10. SARS-CoV-2 vaccine

Top contributors

More